Food, Drugs, Healthcare, Life Sciences

In part two of this three-part series on the Attorney General Alliance (AGA) 2025 Annual Meeting, we highlight panelists' discussions on the safety and regulation of GLP-1...

The impact of the Ruling on the Simmonds' case will inevitably play out into the future.

The New York State Legislature this week approved a bill which, if signed into law by Governor Hochul, would allow on-premises licensees to purchase limited quantities of wine and liquor directly from liquor stores.

On June 8, 2012, Genentech’s lawsuit seeking a declaration that US Patent No. 6,733,752 was invalid and not-infringed by Genentech’s trastuzumab product (HERCEPTIN).

Health Canada specifically contemplates certain proteins as SEBs in its Guidance, although Health Canada has not limited SEBs to only particular classes of drugs.

On May 23, 2012, the Federal Court held that Merck Frosst Canada Ltd. ("Merck") is liable to Apotex Inc. ("Apotex") for damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations (the "Regulations"), but exercised its discretion to reduce the amount of compensation payable based on a defence of ex turpi causa.

Health care professionals - it is likely that you or a colleague you know has been contacted by the HCCC and/or AHPRA.

Medical records are obviously a crucial part of a patient's health journey, documenting important information at key points in time during that journey. Such records are a fundamental and necessary resource...

Healthcare employers in Texas face new requirements for non-competition agreements following the passage of Senate Bill 1318.

On June 11, 2025, was published in the DOF the "AGREEMENT recognizing as equivalent the requirements established in the Health Regulation and the technical evaluation procedures...

On June 12, 2025, BioNTech SE ("BioNTech") announced its entry into a definitive purchase agreement to acquire all shares of CureVac N.V. ("CureVac"), with an implied aggregate equity value for CureVac of approximately $1.25 billion.

TheraPsil, a patient advocacy organization, and 73 healthcare practitioners (HCPs) have succeeded in the Federal Court of Appeal (FCA) to overturn the refusal of the Minister of Mental Health...